Highlights of Ophthalmology

Register      Login

VOLUME 40 , ISSUE 4ENG ( Aug-2012, 2012 ) > List of Articles

REVIEW ARTICLE

Preferred Control of Chronic Open Angle Glaucoma: Medications vs Surgery

Laura A. Crawley, Philip Bloom, M. Francesca Cordeiro

Citation Information : Crawley LA, Bloom P, Cordeiro MF. Preferred Control of Chronic Open Angle Glaucoma: Medications vs Surgery. 2012; 40 (4ENG):9-17.

DOI: 10.5005/hoo-10101-40402

Published Online: 25-08-2012

Copyright Statement:  Copyright © 2012; Jaypee Brothers Medical Publishers (P) Ltd.


Abstract

PDF Share
  1. Quigley HA. Glaucoma. Lancet 2011;377:1367-77
  2. Foster PJ, Buhrmann R, Quigley HA, Johnson GJ. The definition and classification of glaucoma in prevalence surveys. Br J Ophthalmol 2002;86:238-42
  3. Collaborative Normal Tension Glaucoma Study Group. Comparison of glaucomatous progression between untreated patients with normal tension glaucoma and patients with therapeutically reduced intraocular pressures. Am J Ophthalmol 1998;126:487-497
  4. European Glaucoma Society. Terminology and Guidelines for Glaucoma. 3rd edition. Savona, Italy. Dogma:2008
  5. Crawley L, Zamir SM, Cordeiro MF & Guo L. Clinical Options for the reduction of elevated intraocular pressure. Ophth & Eye Diseases 2012;4:1-22
  6. Bean GW, Camras CB. Commercially available prostaglandin analogs for the reduction of intraocular pressure: Similarities and differences. Surv Ophthalmol 2008;53(Suppl 1):S69-S84
  7. Yamagishi R, Aihara M & Araie M. Neuroprotective effects of prostaglandin analogues on retinal ganglion cell death independent of intraocular pressure reduction. Exp Eye Res 2011;93:265-270
  8. Fraser SG, Wormwald RP. Hospital episode statistics and changing trends in glaucoma surgery. Eye 2008;22:3-7
  9. Kenigsberg PA. Changes in medical and surgical treatments of glaucoma between 1997 and 2003 in France. Eur J Ophthalmol 2007;17:521-7
  10. Strutton DR, Walt JG. Trends in glaucoma surgery before and after the introduction of new topical glaucoma pharmacotherapies. J Glaucoma 2004;13:221-6
  11. Van der Valk R, Schouoten JS, Webers CA et al. The impact of a nationwide introduction of new drugs and a treatment protocol for glaucoma on the number of glaucoma surgeries. J Glaucoma 2005;14:239-42
  12. Brubaker RF, Schoff EO, Nau CB et al. Effects of AGN 192024, a new ocular hypotensive agent, on aqueous dynamics. Am J Ophthalmol 2001;131:19-24
  13. Watson P, Stjernschantz J. A six-month randomised double blind study comparing the effects of latanoprost and timolol on primary open angle glaucoma and ocular hypertension. The Latanoprost Study Group. Ophthalmology 1996;103(1):126- 137
  14. Waewar RE, Bullock JD, Ballal D. Cystoid macular oedema and anterior uveitis associated with latanoprost use. Ophthalmology 1998;105:263-268
  15. Gandolfi SA, Cimino L. Effect of bimatoprost on patients with primary open angle glaucoma or ocular hypertension who are non-responders to latanoprost. Ophthalmology 2003;110(3):609-614
  16. Hayreh SS, Podhajsky P, Zimmerman MB. Beta-blocker eyedrops and nocturnal arterial hypotension. Am J Ophthalmol 1999;128:301-309
  17. Higginbotham BJ, Schuman JS, Goldberg I et al. Bimatoprost Study Group 1 and 2. One-year randomised study comparing Bimatoprost and Timolol in glaucoma and ocular hypertension. Arch Ophthalmol 2002;120:1286-1289
  18. Alm A, Camras CB, Watson PG. Phase III latanoprost studies in Scandinavia, the United Kingdom and the United States. Surv Ophthalmol 1997;41(Suppl 2):S105-S110
  19. Netland PA, Landry T, Sullivan EK et al. Travoprost compared with latanoprost and timolol in patients with open angle glaucoma or ocular hypertension. Am J Ophthalmol 2001;132(4):472-484
  20. Sherwood M, Brandt J. Six-month comparison of bimatoprost once daily and twice daily with timolol twice daily in patients with elevated intraocular pressure. Surv Ophthalmol 2001;45(Suppl 4):S361-S368
  21. Noecker RS, Dirk MS, Choplin NT, Bernstein P, Batoosingh AL, Whitcup SM for the Bimatoprost/Latanoprost Study Group. A six-month randomised clinical trial comparing the IOP lowering efficacy of bimatoprost and latanoprost in patients with ocular hypertension or glaucoma. Am J ophthalmol 2003;135(1):55-63
  22. Parrish RK, Palmberg P, Sheu WP for the XLT Study Group. A comparison of latanoprost, bimatoprost and travoprost in patients with elevated intraocular pressure: A 12-week randomised masked-evaluator multicentre study. Am J Ophthalmol 2003;135(5):688-703
  23. Azuma I, Masuda K, Kitazawa Y, Yamamura H. Double masked comparative study of UF-021 and timolol ophthalmic solutions in patients with primary open angle glaucoma or ocular hypertension. Jpn J Ophthalmol 1993;37:514-525
  24. Takagi Y, Nakajima T, Shimazaki A et al. Pharmacological characteristics of AFP- 168 (tafluprost), a new prostanoid FP receptor agonist, as an ocular hypotensive drug. Exp Eye Res 2004;78(4):767-776
  25. Ishida N, Odani-Kawabata N, Shimazaki A, Hara H. Prostanoids in the therapy of glaucoma. Cardiovasc Drug Rev 2006;24(1):1-10
  26. Sutton A, Gilvarry A, Ropo A. A comparative placebo controlled study of prostanoid fluoroprostaglandin receptor agonists tafluprost and latanprost in healthy males. J Ocul Pharmacol Ther 2007;23(4):359-365
  27. Brasnu E, Brignole-Baudouin F, Riancho L, Guenon JM, Warnet JM, Baudouin C. In vitro effects of preservative free tafluprost and preserved latanoprost, travoprost and bimatoprost in a conjunctival epithelial cell line. Curr Eye Res 2008;33(4):303-312
  28. Baudouin C. Detrimental effects of preservative in eye drops: implications for the treatment of glaucoma. Acta Ophthalmol 2008;86(7):716-26
  29. Sutton A, Gouws P, Ropo A. Tafluprost, a new potent prostanoid FP-receptor agonist: a dose response study on pharmacodynamics and tolerability in healthy volunteers. Int J Clin Pharmacol Ther 2008;46(8):400-406
  30. Hedman K, Alm A. A pooled-data analysis of three randomised double masked six-month clinical studies comparing the intraocular pressure reducing effect of latanoprost and timolol. Eur J Ophthalmol 2000;10:95-104
  31. European Glaucoma Prevention Study Group (EGPS) Ophthalmology 2002;109:1612-21
  32. European Glaucoma Society. Terminology and Guidelines for Glaucoma. 3rd edition. Savona, Italy. Dogma:2008
  33. Hutzlemann J, Owens S, Shedden A, Adamsons I, Vargas E. Comparison of the safety and efficacy of fixed combination of dorzolamide/timolol and the concomitant administration dorzolamide and timolol: a clinical equivalence study. International Clinical Equivalence Study Group. Br J Ophthalmol 1998;82(11)1249-53
  34. Clineschmidt CM, Williams RD, Snyder E, Adamsons IA. A randomised trial in patients inadequately controlled with timolol alone comparing the dorzolamidetimolol combination to monotherapy with timolol or dorzolamide. Dorzolamide- Timolol Combination Study Group. Ophthalmology 1998;105(10):1952-9
  35. Sherwood MB, Craven ER, Chou C et al. Twice daily 0.2% brimonidine-0.5% timolol fixed combination therapy vs monotherapy with timolol or brimonidine in patients with glaucoma or ocular hypertension: a 12-month randomised trial. Arch Ophthalmol 2006;124(9):1230-8
  36. Goni FJ. Brimonidine/Timolol fixed combination study group. 12-week study comparing the fixed combination of brimonidine and timolol with concomitant use of the individual components in patients with glaucoma and ocular hypertension. Eur J Ophthalmol 2005;15(5):581-90
  37. Konstas AG, Katsimpris IE, Kaltsos K et al. Twenty-four hour efficacy of the brimonidine/timolol fixed combination versus therapy with the unfixed components. Eye 2008;22(11):1391-7
  38. Konstas AG, Quaranta L, Yan DB et al. Twenty- four hour efficacy with the dorzolamide/timolol fixed combination compared with the brinzolamide/timolol fixed combination in primary open angle glaucoma. Eye 2011. Sep 30. doi:10. 1038/eye.2011.239 [Epub ahead of print]
  39. Pfeiffer N; European Latanoprost Fixed Combination Study Group. A comparison of the fixed combination of latanoprost and timolol with its individual components. Graefes Arch Clin Exp Ophthalmol 2002;240:893-899
  40. Higginbotham EJ, Diestelhorst M, Pfeiffer N et al. The efficacy and safety of unfixed and fixed combinations of latanoprost and other antiglaucoma medications. Surv Ophthalmol 2002;47(Suppl 1):S133-S140
  41. Barneby H, Orengo-Nania S, Flowers BE et al. The safety and efficacy of travoprost 0.004%/Timolol 0.5% fixed combination ophthalmic solution. Am J Ophthalmol 2005;140:1-7
  42. Diestelhorst M, Larsson LI. European Latanoprost Fixed Combination Study Group. A 12-week study comparing the fixed combination of latanoprost and timolol with the concomitant use of the individual components in patients with open angle glaucoma and ocular hypertension. Br J Ophthalmol 2004;88:199- 203
  43. Hughes BA, Bacharach J, Craven ER et al. A three-month multi centre double masked study of the safety and efficacy of travoprost 0.004%/timolol 0.5% ophthalmic solution compared to travoprost 0.004% ophthalmic solution and timolol 0.5% dosed concomitantly in subjects with open angle glaucoma and ocular hypertension. J Glaucoma 2005;14:392-399
  44. Brandt JD, Cantor LB, Katz LJ, Batoosingh AL, Chou C, Bossowska I; Ganfort Investigators Group II. Bimatoprost/timolol fixed combination: a 3-month double masked randomised parallel comparison to its individual components in patients with glaucoma or ocular hypertension. J Glaucoma 2008;17(3):211-6
  45. Hommer A. Ganfort Investigators Group I. A double masked randomised parallel comparison of a fixed combination of bimatoprost 0.03%/timolol 0.5% with nonfixed combination use in patients with glaucoma or ocular hypertension. Eur J Ophthalmol 2007;17(1):53-62
  46. Webers CA, Becjers HJ, Zeegers MP, Nuijts RM, Hendrikse F, Schouten JS. The intraocular pressure lowering effect of prostaglandin analogues combined with topical ? blocker therapy: a systematic review & meta-analysis. Ophthalmology 2010;117(11):2067-74
  47. Boyle JE, Ghosh K, Gieser DK et al. A randomised trial comparing dorzolamide/timolol combination given twice daily to monotherapy with timolol and dorzolamide. Ophthalmology 1998;105(10):1945-51
  48. Sall KN, Greff LJ, Johnson-Pratt LR et al. Dorzolamide/timolol combination versus concomitant administration of brimonidine and timolol: a six-month comparison of efficacy and tolerability. Ophthalmology 2003;110(3):615-24
  49. Olthoff C, Schouten JvdB, Webers CA. Non-compliance with ocular hypotensive treatment in patients with glaucoma or ocular hypertension: an evidence based review. Ophthalmol 2005;112:953-961
  50. Dreer LE, Girkin C, Manskerger SL. Determinants of medication adherence to topical glaucoma therapy. J Glaucoma 2012;21:234-240
  51. Lacey J, Cate H, Broadway D. Barriers to adherence in glaucoma medications: a qualitative research study. Eye 2008;23:924-32
  52. Tsai J, McClure C, Ramos S et al., Compliance barriers in glaucoma, a systematic classification. J Glaucoma 2003;12:343-398
  53. Freidman D, Hahn S, Gelb L et al. Doctor-patient communication, health related beliefs & adherence in glaucoma: results from the Glaucoma Adherence Persistency study. Ophthalmology 2008;115:1320-27
  54. Krasnov MM. Laser puncture of the anterior chamber angle in glaucoma (a preliminary report) [In Russian]. Vest Oftalmol 1972;3:27-31
  55. Wise JB, Witter SL. Argon laser therapy for open angle glaucoma: a pilot study. Arch Ophthalmol 1979;97:319-22
  56. Goyal S, Beltran-Agilluo L, Rashid S, Shah S, Nath R, Obi A & Lim KS. Effect of primary selective laser trabeculoplasty on tonographic outflow facility: a randomised clinical trial. Br J Ophthalmol 2010;94:1443-1447
  57. Rolim de Moura CR, Paranhos Jr. A, Wormald R. Laser trabeculoplasty for open angle glaucoma. Cochrane Database of Systematic Reviews 2007, Issue 4 Art No.: CD003910. DOI:10.1002/12651858.CD003919.pub2.
  58. Stein JD, Challa P. Mechanisms of action and efficacy of argon laser trabeculoplasty and selective laser trabeculoplasty. Curr Opin Ophthalmol 2007;18:140-145
  59. Glaucoma Laser trial Research Group. The Glaucoma Laser Trial (GLT) and Glaucoma Laser Trial Follow-up Study:7. Results. Am J Ophthalmol 1995;120:718-31
  60. Glaucoma Laser Trial Research Group. The Glaucoma Laser Trial (GLT) 2. Results of argon laser trabeculoplasty versus topical medicines. Ophthalmology 1990;97:1403-13
  61. Melamed S, Pei J, Epstein DL. Delayed response to argon laser trabeculoplasty in monkeys: morphological and morphometric analysis. Arch Ophthalmol 1986;104:10778-1083
  62. Melamed S, Pei J, Epstein DL. Short term effect of argon laser trabeculoplasty in monkeys. Arch Ophthalmol 1985;103:1546-62
  63. Van Buskirk EM, Pond V, Rosenquist RC Acott TS. Argon laser trabeculoplasty: studies of mechanism of action. Ophthalmology 1984;91:1005-1010
  64. Cvenkel B. One-year follow up of selective laser trabeculoplasty in open angle glaucoma. Ophthalmologica 2004;218:20-25
  65. Gracner T. Intraocular pressure reduction after selective laser trabeculoplasty in primary open angle glaucoma. Collegium Antropologicum 2001;25(Suppl):S111-S115
  66. Gracner T. Intraocular pressure response of capsular glaucoma and primary open angle glaucoma to selective Nd:YAG laser trabeculoplasty: a prospective comparative clinical trial. Eur J Ophthalmol 2002;12:287-292
  67. Johnson PB, Katz LJ, Rhee DJ. Selective laser trabeculoplasty: predictive value of early intraocular pressure measurements for success at 3 months. Br J Ophthalmol 2006;90:741-743
  68. Kajiya S, Hayakawa K, Sawaguchi S. Clinical results of selective laser trabeculoplasty. Nippon Ganka Gakkai Zasshi Japonicae 2000;104:160-164
  69. Kano K, Kuwayama Y, Mizoue S, Ito N. Clinical results of selective laser trabeculoplasty. Nippon Ganka Gakkai Zasshi Japonicae 1999;103:612-616
  70. Kim YJ, Moon CS. One year follow up of laser trabeculoplasty using Q-switched frequency doubled Nd-YAG laser of 532nm wavelength. Ophthalmic Surg Lasers 2000;31:394-399
  71. Lai JS, Chua JK, Tham CC, Lam DS. Five year selective laser trabeculoplasty in Chinese eyes. Clin Exp Ophthalmol 2004;32:368072
  72. Lanzetta P, Menchini U, Virgili G. Immediate intraocular pressure response to selective laser trabeculoplasty. Br J Ophthalmol 1999;83:29-32
  73. Latina MA, Sibayan SA, Shin DH et al. Q-switched 532nm Nd-YAG laser trabeculoplasty (selective laser trabeculoplasty): a multicentre pilot clinical study. Ophthalmology 1998;105:2082-2088
  74. Melamed S, Ben Simon GJ, Levkovitch-Verbin H. Selective laser trabeculoplasty as a primary treatment for open angle glaucoma; a prospective non randomised pilot study. Arch Ophthalmol 2003;121:957-60
  75. Rozsival P, Kana V, Hovorkova M. Selective laser trabeculoplasty. Ceska a Slovenska Oftalmologie 2004;60:267-274
  76. Song J, Lee PP, Epstein DL et al. High failure rate associated with 180 degrees selective laser trabeculoplasty. J Glaucoma 2005;14:400-408
  77. Nagar M, Ogunyomade A, O'Brart DPS, Howes F & Marshall J. A randomised prospective study comparing selective laser trabeculoplasty with latanoprost for the control of intraocular pressure in ocular hypertension and open-angle glaucoma.
  78. McIlraith I, Strasfield M, Colev G, Hutnik CM. Selective laser trabeculoplasty as initial and adjunctive treatment for open angle glaucoma. J Glaucoma 2006;15:124-130
  79. Barkana Y & Belkin M. Selective laser trabeculoplasty. Surv Ophthalmol 2007;52:634-654
  80. Feldman RM, Katz LJ, Spaeth GL et al. Long-term efficacy of repeat argon laser trabeculoplasty. Ophthalmology 1991;98:1061-65
  81. Richter CU, Shingleton BJ, Bellows Ar et al. Retreatment with argon laser trabeculoplasty. Ophthalmology 1987;94:1085-89
  82. Weber PA, Burton GD, Epitropoulos AT. Laser trabeculoplasty retreatment. Ophthalmic Surg 1989;20:702-706
  83. Grayson DK, Camras CB, Podos SM, Lustgarten JS. Long term reduction of intraocular pressure after repeat argon laser trabeculoplasty. Am J Ophthalmol 1988; 106:312-321
  84. Starita RJ, Fellman RL, Spaeth GL et al. The effect of repeating full circumference argon laser trabeculoplasty. Ophthalmic Surg 1984;15:41-43
  85. Hong BK, Winer JC, Martine JF, Wand M, Altman B & Shields B. Repeat selective laser trabeculoplasty. J Glaucoma 2008;17:287-92
  86. Realini T. Selective laser trabeculoplasty; a review. J Glaucoma 2008;17:497- 502
  87. Samples JR, Singh K, Lin SC et al. Laser trabeculoplasty for open angle glaucoma; A report by the American Academy of Ophthalmology. Ophthalmology 2011. Doi:10.1016/j.ophtha.2011.04.037 [Epub ahead of print]
  88. Burr J, Azuara-Blanco A, Avenell A. Medical versus surgical interventions for open angle glaucoma. Cochrane Database of Systematic Reviews 2004, Issue 2. Art No.: CD004399. DOI: 10.1002/14651858.CD004399.pub2.
  89. Cairns JE, Trabeculectomy. Preliminary report of a new method. Am J Ophthalmol 1968;66:673-679
  90. Lichter PR, Musch DC, Gillespie BW, Guire KE, Janz NK, Wren PA “et al.” CIGTS Study Group. Interim clinical outcomes in the Collaborative Initial Glaucoma Treatment Study comparing initial treatment randomised to medications or surgery. Ophthalmology 2001;108:1943-1953
  91. Migdal C, Hitchings R. Control of chronic simple glaucoma with primary medical, surgical and laser treatment. Trans Ophthalmol Soc UK 1986;105(Pt6):653-6
  92. Kirwan JF, Rennie C, Evans JR. Beta radiation for glaucoma surgery. Cochrane Database of Systematic Reviews 2009, Issue 2. Art No.:CD003433. DOI:1.1002/14651858.CD003433.pub2
  93. Jones E, Clarke J, Khaw PT. Recent advances in trabeculectomy technique. Curr Opin Ophthalmol 2005;16:107-113
  94. Khaw PT. Advances in glaucoma surgery: evolution of antimetabolite adjunctive therapy. J Glaucoma 2001;10(5 Suppl 1):S81-S84
  95. Rez Razeghinejad M, Fudemberg SJ, Spaeth G. The changing conceptual basis of trabeculectomy: A review of past and current surgical techniques. Surv Ophthalmol 2012;57:1-25
  96. Lanvin MJ, Wormald RP, Migdal CS, Hitchings RA. The influence of prior therapy on the success of trabeculectomy. Arch Ophthalmol 1990;108(11):1543-8
  97. Hitchings RA, Grierson I. Clinicopathological correlation in eyes with failed fistulising surgery. Trans Ophth Soc UK 1983;103(Pt1):84-88
  98. Wilkins M, Indar A, Wormald R. Intraoperative Mitomycin C for glaucoma surgery. Cochrane Database of Systematic Reviews 2005, Issue 4.Art No.:CD002897. DOI: 10.1002/14651858.CD002897.pub.2
  99. Cohen LB, Graham TF, Fry WE. Beta radiation; as an adjunct to glaucoma surgery in the Negro. Am J Ophthalmol 1959;47(1 Pt1):54-61
  100. Wormald R, Wilkins M, Bunce C. Postoperative 5-Fluorouracil for glaucoma surgery. Cochrane Database of Systematic Reviews 2001, Issue 3. Art. No.: CD001132.DOI:10.1002/14651858.CD001132.
  101. Fluorouracil Filtering Surgery Study. One year follow-up. Am J Ophthalmol. 1990;109:613-6
  102. Fluorouracil Filtering Surgery Study. One-Year follow-up. The Fluorouracil Filtering Surgery Study Group. Am J Ophthalmol. 1989;108:625-35
  103. Yamamoto T, Varani J, Soong HK et al. Effects of 5FU and MMC on cultured rabbit subconjunctival fibroblasts. Ophthalmology 1990;97:1204-10
  104. Sauder G, Jonas JB. Limbal stem cell deficiency after subconjunctival mitomycin C injection for trabeculectomy. Am J Ophthalmol. 2006;141:1129-1130
  105. Dhingra S, Khaw PT. The Moorfields safer surgery surgery system. Middle East Afr J Ophthalmol 2009;16:112-5
  106. Lama PS & Fechtner RD. Antifibrotics & wound healing in glaucoma surgery. Surv Ophthalmol 2003;48:314-346
  107. Li J, Zhang YP, Kirsner RS. Angiogenesis in wound repair: angiogenic growth factors & the extracellular matrix. Microsc Res Tech 2003;60:107-114
  108. Li Z, Van Bergen T, Van de Veire S et al, Inhibition of vascular endothelial growth factor reduces scar formation after glaucoma filtration surgery. IOVS 2009;56(11):5217-5225
  109. Asahara T, Baulers C, Zheng LP et al, Synergistic effect of vascular endothelial growth factor & basic fibroblast growth factor on angiogenesis in vivo. Circulation 1995;92(9 suppl): II365-II371
  110. Sun XT, Ding YT, Yan XG et al. Angiogenic synergistic effect of basic fibroblast growth factor & vascular endothelial growth factor in an in-vitro qualitative micro carrier-based 3d fibrin angiogenesis system. World J Gastroenterol 2004;10:2524-2528
  111. Van Bergen T, Vandewalle E, Van de Veire S, Dewerchin M, Stassen JM, Moons L, Stalmans I. The role of different VEGF isoforms in scar formation after glaucoma filtration surgery. Exp Eye Res 2011;93(5):689-99
  112. Nilforushan N, Yahgar M, Khosh Kish S & Nassiri N. Subconjunctival bevacizumab versus mitomycin C adjunctive to trabeculectomy. Am J Ophthalmol 2012;153:352-357
  113. Chua BE, Nguyen DQ, Qin Q, Ruddle JB, Wells AP, Niyadurupola N, Gupta V, Wong TT, Coote MA, Crowston JG. Bleb vascularity following post trabeculectomy subconjunctival bevacizumab: a pilot study. Clin Experiment Ophthalmol 2012 do i10.1111/j.1442-9071.2012.02798 publication ahead of print
  114. Minckler DS, Francis BA, Hodapp EA et al. Aqueous shunts in Glaucoma: A report by the American Academy of Ophthalmology. Ophthalmology 2003;115:1089- 1098
  115. Hong CH, Arosemena A, Zurakowski D, Ayyala RS, Glaucoma drainage devices: a systematic literature review and current controversies. Surv Ophthalmol 2005;50:48-60
  116. Geddes SJ, Heuer DK, Parrish II RK. The Tube Versus Trabeculectomy Study Group. Review of results from the tube versus trabeculectomy study. Curr Opin Ophthalmol 2010;21:123-128
  117. Ramulu PY, Corcoran KJ, Corcoran SL, Robin AL. Utilisation of various glaucoma surgeries and procedures in Medicare beneficiaries from 1995 to 2004. Ophthalmology 2007;114:2265-2270
  118. Geddes SJ, Schiffman JG, Feuer WJ, Herndon LW, Brandt JD, Budenz DL. Treatment outcomes in the tube versus trabeculectomy study after 5 years of follow up. Am J Ophthalmol 2012;153:789-803
  119. Geddes SJ, Herndon LW, Brandt JD, Budenz DL, Feuer WJ & Schiffman JG. Postoperative complications
  120. Jampel HD, Musch DC, Gillespie BW et al. Perioperative complications of trabeculectomy in the Collaborative Initial Glaucoma Treatment Study. Am J Ophthalmol 2005;140:16-22
  121. Caprioli J. The tube vs trabeculectomy study: why its findings may not change clinical practice. Am J Ophthalmol 2011;151:742-744
  122. AGIS investigators. The advanced glaucoma intervention study: AGIS 11. Risk factors for failure of trabeculectomy and argon laser trabeculoplasty. Am J Ophthalmol 2002;134:481-498
  123. Dahan E, Drusedau MU. Nonpenetrating filtration surgery for glaucoma: control by surgery only. J Cataract Refract Surg 2000;26:695-701
  124. Sarodia U, Shaarawy T, Barton K. Nonpenetrating glaucoma surgery: a critical evaluation. Curr Opin Ophthalmol 2007;18:152-158
  125. Mendrinos E, Mermoud A, Shaarawy T. Nonpenetrating glaucoma surgery. Surv Ophth 2008;53(6):592-630
  126. Shaarawy T, Mermoud A. Deep sclerectomy in one eye versus deep sclerectomy with implant in the contralateral eye of the same patient: long term follow up. Eye 2005;19:298-302
  127. Dahan E, Ravinet E, Ben-Simon GJ, Mermoud A. Comparison of the efficacy and longevity of nonpenetrating glaucoma surgery with and without a new nonabsorbable hydrophilic implant. Ophthalmic Surg Lasers Imaging 2003;34:457-63
  128. Shaarawy T, Nguyen C, Schnyder C, Mermoud A. Comparative study between deep sclerectomy with and without collagen implant: long term follow up. Br J Ophthalmol 2004;88:95-8
  129. Demailly P, Lavat P, Kretz G, Jeanteur-Lunel MN. Nonpenetrating deep sclerectomy (NPDS) with or without collagen device (CD) in primary open angle glaucoma: middle term retrospective study. Int Ophthalmol 1996;20:131-40
  130. Lachkar Y, Neverauskiene J, Jeanteur-Lunel MN et al. Nonpenetrating deep sclerectomy: a 6 year retrospective study. Eur J Ophthalmol 2004;14:26-36
  131. Hamard P, Lachkar Y. Nonpenetrating filtering surgery, evolution and results. J Fr Ophthalmol 2002;225:527-36
  132. El Sayyad F, Helal M, El-Kholify H et al. Nonpenetrating deep sclerectomy versus trabeculectomy in bilateral primary open angle glaucoma. Ophthalmology 2000;107:1671-1674
  133. Carassa RG, Bettin P, Fiori M, Brancato R. Viscocanalostomy versus trabeculectomy in white adults affected by open angle glaucoma: a 2-year randomised controlled trial. Ophthalmology 2003;110:882-7
  134. Kobayashi H, Kobayashi K. Randomised comparison of the intraocular pressure lowering effect of phacotrabeculectomy. Ophthalmology 2007;114:909-14
  135. O'Brart DP, Rowlands E, Islam N, Noury AM. A randomised prospective study comparing trabeculectomy augmented with antimetabolites with a viscocanalstomy technique for the management of open angle glaucoma uncontrolled by medical therapy. Br J Ophthalmol 2002;86:748-54
  136. O'Brart DP, Shiew M, Edmunds B. A randomised prospective study comparing trabeculectomy with viscocanalostomy with adjunctive antimetabolite usage for the management of open angle glaucoma uncontrolled by medical management. Br J Ophthalmol 2002;88:1012-7
  137. Koerber NJ. “Canaloplasty in one eye compared with viscocanalostomy in the contralateral eye in patients with bilateral open angle glaucoma.” J Glaucoma 2012;21(2):129-34
  138. Yalvac IS, Sahin M, Eksioglu U et al. Primary viscocanalostomy versus trabeculectomy for primary open angle glaucoma: three year prospective randomised clinical trial. J Cataract Refract Surg 2004;30:2050-7
  139. Stegmann R, Pienaar A, Miller D. Viscocanalostomy for open angle glaucoma in black African patients. J Cataract Refract Surg 1999;25:316-22
  140. Sunaric-Megevand G, Leuenberger P. Results of viscocanalostomy for primary open angle glaucoma. Am J Ophthalmol 2001;132:221-28
  141. Luke C, Dietlein TS, Jacobi PC et al. A prospective randomised trial of viscocanalostomy with and without implantation of a reticulated hyaluronic acid implant (SKGEL) in open angle glaucoma. Br J Ophthalmol 2003;87:599-603
  142. Francis BA, Singh K, Lin SC. Novel glaucoma procedures: A report by the American Academy of Ophthalmology. Ophthalmology 2011;118:1466-1480
  143. Lewis RA, vonWolff K, Tetz M et al., Canaloplasty: circumferential viscodilation and tensioning of Schlemm's canal using a flexible microcatheter for the treatment of open angle glaucoma in adults. J Cataract Refract Surg. 2007;33:1217-26
  144. Wamsley S, Moster MR, Rai S et al, Results of the use of the Ex-PRESS miniature glaucoma implant in technically challenging, advanced glaucoma cases: a clinical pilot study. Am J Ophthalmol 2004;138:1049-51
  145. Dahan E, Carmichael TR. Implantation of a miniature glaucoma device under a scleral flap. J Glaucoma 2005;14:98-102
  146. Maris PJ Jr, Ishida K, Netland PA. Comparison of trabeculectomy with Ex- PRESS miniature glaucoma device implanted under scleral flap. J Glaucoma 2007;16:14-19
  147. Traverso CE, De Feo F, Messas-Kaplan A et al. Long term effect on IOP of a stainless steel glaucoma drainage implant (Ex-PRESS) in combined surgery with phacoemulsification. Br J Ophthalmol 2005;89:425-9
  148. Rivier D, Roy S, Mermoud A. Ex-PRESS R-50 miniature glaucoma implant insertion under the conjunctiva combined with cataract extraction. J Cataract Refract Surg 2007;33:1946-52
  149. Dow CT, deVenecia G. Transciliary filtration (Singh filtration) with the Fugo plasma blade. Ann Ophthalmol (Skokie) 2008;40:8-14
  150. Singh D, Singh K. Transciliary filtration using the Fugo Blade. Ann Ophthalmol (Skokie) 2002;34:183-7
  151. Fea AM. Phacoemulsification vs Phacoemulsification with microbypass stent implantation in primary open angle glaucoma: Randomised double masked clinical trial. J Cataract Refract Surgery 2010:36;407-12
  152. Spiegel D, Wetzel W, Haffner DS, Hill RA. Initial clinical experience with the trabecular micro-bypass stent in patients with glaucoma. Adv Ther 2007;24:161- 70
  153. Spiegel D, Garcia-Feijoo J, Garcia-Sanchez J, Lamielle H. Coexistent primary open angle glaucoma and cataract: preliminary analysis of treatment by cataract surgery and the iStent trabecular micro-bypass stent and concurrent cataract surgery. Adv Ther 2008;25:453-64
  154. Spiegel D, Wetzel W, Neuhann T et al. Coexistent primary open angle glaucoma and cataract: interim analysis of treatment by cataract surgery and the iStent trabecular micro-bypass stent and concurrent cataract surgery. Eur J Ophthalmol 2009;19:393-9
  155. Minckler DS, Baerveldt G, Alfaro MR, Francis BA. Clinical results with the Trabectome for treatment of open-angle glaucoma. Ophthalmology 2005;112:962-7
  156. Minckler DS, Baerveldt G, Ramirez MA et al. Clinical results with the Trabectome, a novel surgical device for treatment of open angle glaucoma. Trans Am Ophthalmol Soc 2006;104:40-50
  157. Francis VA, Minckler D, Dustin L et al. Trabectome Study Group. Combined cataract extraction and trabeculotomy by the internal approach for coexisting cataract and open angle glaucoma: initial results. J Cataract Refract Surg 2008;34:1096-103
  158. Singh D, Bundela R, Agarwal A et al. Goniotomy ab interno “a glaucoma filtering surgery” using the Fugo Plasma Blade. Ann Ophthalmol (Skokie) 2002;34:183-7
  159. Wilmsmeyer S, Philippin H, Funk J. Excimer laser trabeculotomy: a new, minimally invasive procedure for patients with glaucoma. Graefes Arch Clin Exp Ophthalmol 2006;244:670-6
  160. Babighian S, Rapizzi E, Galan A. Efficacy and safety of ab interno excimer laser trabeculotomy in primary open angle glaucoma: two years of follow-up. Ophthalmologica 2006;220:285-90
  161. Saheb H & Ahmed IIK. Micro-invasive glaucoma surgery: current perspectives & future directions. Curr Opinion Ophthalmol 2012;23:96-104
  162. Melamed S, Ben Simon GJ, Goldenfeld M, Simon G. Efficacy and safety of gold micro shunt implantation to the supraciliary space in patients with glaucoma: a pilot study. Arch Ophthalmol 2009;127:264-9
  163. Figus M, Lazzeri S, Fogagnolo P, Lester M, Martinelli P & Nardi M. Supraciliary shunts in refractory glaucoma. Br J Ophthalmol 2011;95:1537-1541
  164. Agnifili L, Costagliola C, Figus M et al. Histological findings of failed gold micro shunts in primary open angle glaucoma. Graefes Arch Clin Exp Ophthalmol 2011;Aug 23 epublication ahead of print. DOI: 10.1007/s00417-011-1778-6
  165. Budenz DL, Barton K, Feuer WJ, Schiffman J, Costa VP, Godfrey DG& Buys Y. Treatment outcomes in the Ahmed Baerveldt Comparison study after one year of follow up. Ophthalmology 2011;118:443-452
  166. Ramulu PY, Corcoran KJ, Corcoran SL, Robin AL. Utilisation of various glaucoma surgeries and procedures in Medicare beneficiaries from 1995 to 2004. Ophthalmology 2007;114:2265-2270.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.